Table 1.
D-dimer, ferritin, and C-reactive protein levels measured during the patient's hospitalization
Day from admission |
|||||||||
---|---|---|---|---|---|---|---|---|---|
1 | 3a | 6 | 8 | 10b | 12 | 13c | 35 | 40 | |
D-dimer (μg/ml) | 1.9 | 2.1 | 2.8 | 2.6 | 4.6 | 4.9 | 9.8 | 2.6 | 2.7 |
Ferritin (ng/ml) | >10 000 | >10 000 | 7380 | 3185 | 3000 | 2820 | 3850 | 655 | 844 |
C-reactive protein (mg/l) | 170 | 165 | 101 | 127 | 151 | 164 | 179 | 19 | 11 |
Anakinra initiation.
Anakinra cessation.
Day of deterioration and recombinant tissue plasminogen activator (rt-PA)/tocilizumab administration.